VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $27,000 | +22.7% | 1,106 | 0.0% | 0.07% | +7.2% |
| Q2 2016 | $22,000 | -24.1% | 1,106 | 0.0% | 0.07% | -28.9% |
| Q1 2016 | $29,000 | -74.1% | 1,106 | 0.0% | 0.10% | -72.7% |
| Q4 2015 | $112,000 | -43.1% | 1,106 | 0.0% | 0.36% | -45.0% |
| Q3 2015 | $197,000 | -19.9% | 1,106 | 0.0% | 0.64% | -11.2% |
| Q2 2015 | $246,000 | +11.8% | 1,106 | 0.0% | 0.73% | +14.0% |
| Q1 2015 | $220,000 | +39.2% | 1,106 | 0.0% | 0.64% | +42.8% |
| Q4 2014 | $158,000 | +15700.0% | 1,106 | +10960.0% | 0.45% | +14766.7% |
| Q3 2014 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $1,000 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |